These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3429985)

  • 21. [Detection of rubella-specific IgM by an immunoenzyme technic].
    Fortier B; Nicolas JC; Bricout F
    Pathol Biol (Paris); 1983 Sep; 31(7):599-600. PubMed ID: 6355991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of various serological methods and diagnostic kits for the detection of acute, recent, and previous rubella infection, vaccination, and congenital infections.
    Enders G; Knotek F; Pacher U
    J Med Virol; 1985 Jul; 16(3):219-32. PubMed ID: 2993493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of a rapid method for determining primary infection by rubella virus].
    Nates S; Ferreira Centeno A; Márquez A; Zapata M
    Rev Argent Microbiol; 1987; 19(4):153-9. PubMed ID: 2845475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemagglutination inhibition, single radial hemolysis, and ELISA tests for the detection of IgG and IgM to rubella virus.
    Champsaur H; Dussaix E; Tournier P
    J Med Virol; 1980; 5(4):273-86. PubMed ID: 7014780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of seronegative high-risk populations with attenuated rubella vaccine.
    Lehtinen MO; Hakkarainen K; Leinikki PO; Lehtinen TK; Mattila LM; Helle EP
    Ann Clin Res; 1982 Dec; 14(5-6):213-9. PubMed ID: 7171230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the effects of active rubella vaccination. Comparative studies of the evaluation of seroconversion using the ELISA technic and the hemagglutination inhibition test].
    Dennin RH; Husstedt W
    Fortschr Med; 1983 Mar; 101(11):482-5. PubMed ID: 6343205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in antibody titre after rubella vaccination in primarily rubella-sera positive parturient women. Demonstration of antigen-specific (rubella) and non-specific stimulated antibody titres (author's transl)].
    Doerr HW; Geisen HP; Kapp M; Schmidt W
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1316-20. PubMed ID: 6257468
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selective and controlled mass rubella vaccination - experiences with an economical method (author's transl)].
    Zippel C; Federmann G; Leidel J; Eggers HJ
    Immun Infekt; 1982 Mar; 10(2):69-75. PubMed ID: 7040210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Avidity of rubella IgG antibody in rubella virus infection].
    Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1389-93. PubMed ID: 8270822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
    Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different methods for assessment of rubella infection and immunity.
    Braun R; Hornig C; Sann G; Doerr HW
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):431-7. PubMed ID: 6758420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-serum diagnosis of recent rubella infection with the use of hemagglutination inhibition test and enzyme-linked immunosorbent assays.
    Katow S; Sugiura A; Janejai N
    Microbiol Immunol; 1989; 33(2):141-5. PubMed ID: 2716546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies.
    Gerna I; Zannino M; Revello MG; Petruzzelli E; Dovis M
    J Clin Microbiol; 1987 Jun; 25(6):1033-8. PubMed ID: 3597747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.